chemotherapy

FDA Approves Groundbreaking Postmortem Chemotherapy Protocol

  • 492
    Shares

BOCA RATON, FL – Sending shockwaves throughout the medical community, the Food & Drug Administration approved a postmortem chemotherapy regimen to be administered after a patient has passed away from cancer. The protocol will initially be offered to patients who have succumbed to disease within 1 month of their death, but there are rumblings that the toxic medications could eventually be administered as late as 1 to 5 years after the patient has died.

chemotherapyArea oncologist Dr. Sri-Sheshadariprativadibayankaram, whose groundbreaking research paved the way for this breakthrough, hailed the FDA announcement as a step forward.  “This treatment plan offers a ray of hope to those who are no longer with us.  Even though our data indicates a 0% chance of resurrection from death, I think it’s important for us to give patients the option.”

While insurance companies have been reluctant to offer coverage for this ultra-expensive chemotherapy regimen, the pharmaceutical industry has launched a marketing campaign which urges patients to consider postmortem payment plans to receive the regimen in a cash-pay model. 

Taking the lead from Dr. Sri-Sheshadariprativadibayankaram, many other specialists suggest that additional postmortem medical breakthroughs may be on the horizon:

“These are truly exciting times in medicine!” raved Dr. Sri-Sheshadariprativadibayankaram.  “What a time to be alive, or even already dead!”

image_pdfimage_print
  • Show Comments

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

You May Also Like

Pyxis Seven Blunders

Meet the Nominees for the Seven Blunders of the Medical World

2.1KSharesWe, at Gomerblog, are excited to announce the official list of nominees for the ...

Alex Trebek

Doctor Gets Pulled for Jeopardy, Wins $24,000

123SharesBURBANK, CA – Steven Lowell was bummed that in the early hours of his ...